Abstract
3/2008
vol. 3
Evaluation of effectiveness of infliximab in the treatment of perianal form of Crohn’s disease in a 16-year old girl
Przegląd Gastroenterologiczny 2008; 3 (3): 161–164
Online publish date: 2008/06/09
Pathogenesis of Crohn’s disease is still unknown. Biological therapy with anti-TNF-α antibodies is nowadays used in the treatment. In the therapeutic guidelines treatment with infliximab is presented. We present a case study of a 16-year old girl with perianal form of Crohn’s disease. After the use of biological therapy perianal changes were cured and remission was obtained.
Keywords
Crohn’s disease, infliximab
Coverage in
Indexed in
Integrated with
